Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FANFT is a **synthetic nitrofuran derivative** with the chemical name **N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide** and molecular formula C8H5N3O4S[7]. It is a **dark yellow powder or gold solid** and is **insoluble in water**[2]. FANFT is primarily used as a research chemical and is recognized as a **potent urinary bladder carcinogen** in animal studies[8][2][6]. Its carcinogenic and mutagenic effects serve as a model for studying chemical carcinogenesis, particularly related to nitrofuran derivatives, affecting organs such as the bladder, forestomach, mammary gland, and kidney[2][8]. Its mechanism of toxicity involves metabolic activation likely associated with the nitro group on the furan ring. FANFT has demonstrated mutagenic and reproductive toxicity in experimental systems[2]. It is not intended for human or veterinary use[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fanft.